Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 197,091Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Veranova, L.P.

02 1Agno Pharma Jiangsu

03 1American Pacific Corporation

04 1Apothecon Pharmaceuticals Pvt Ltd

05 1Aurobindo Pharma Limited

06 1Emcure Pharmaceuticals Limited

07 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.

08 1MSN Laboratories Private Limited

09 1NATCO PHARMA LIMITED

10 1Piramal Pharma Solutions Inc.

11 1Zhejiang ChemPacific Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

CARMUSTINE

NDC Package Code : 50137-0686

Start Marketing Date : 2014-06-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/1)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

Veranova

02

The Aesthetic Show
Not Confirmed
arrow
arrow
The Aesthetic Show
Not Confirmed

CARMUSTINE

NDC Package Code : 57821-002

Start Marketing Date : 2018-06-06

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

The Aesthetic Show
Not Confirmed
arrow
arrow
The Aesthetic Show
Not Confirmed

CARMUSTINE

NDC Package Code : 50683-0017

Start Marketing Date : 1972-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

The Aesthetic Show
Not Confirmed
arrow
arrow
The Aesthetic Show
Not Confirmed

CARMUSTINE

NDC Package Code : 59651-168

Start Marketing Date : 2024-01-10

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

05

The Aesthetic Show
Not Confirmed
arrow
arrow
The Aesthetic Show
Not Confirmed

CARMUSTINE

NDC Package Code : 59981-034

Start Marketing Date : 2016-03-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

06

The Aesthetic Show
Not Confirmed
arrow

07

The Aesthetic Show
Not Confirmed
arrow
arrow
The Aesthetic Show
Not Confirmed

CARMUSTINE

NDC Package Code : 57884-0032

Start Marketing Date : 2017-11-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (2kg/2kg)

Marketing Category : BULK INGREDIENT

blank

08

The Aesthetic Show
Not Confirmed
arrow

09

The Aesthetic Show
Not Confirmed
arrow
arrow
The Aesthetic Show
Not Confirmed

CARMUSTINE

NDC Package Code : 70225-1107

Start Marketing Date : 2020-02-19

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

The Aesthetic Show
Not Confirmed
arrow
arrow
The Aesthetic Show
Not Confirmed

CARMUSTINE

NDC Package Code : 58621-002

Start Marketing Date : 2020-12-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/30mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

Looking for 154-93-8 / Carmustine API manufacturers, exporters & distributors?

Carmustine manufacturers, exporters & distributors 1

54

PharmaCompass offers a list of Carmustine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carmustine manufacturer or Carmustine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carmustine manufacturer or Carmustine supplier.

PharmaCompass also assists you with knowing the Carmustine API Price utilized in the formulation of products. Carmustine API Price is not always fixed or binding as the Carmustine Price is obtained through a variety of data sources. The Carmustine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Carmustine

Synonyms

154-93-8, 1,3-bis(2-chloroethyl)-1-nitrosourea, Bcnu, Gliadel, Carmubris, Carmustin

Cas Number

154-93-8

Unique Ingredient Identifier (UNII)

U68WG3173Y

About Carmustine

A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)

Nitrumon Manufacturers

A Nitrumon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitrumon, including repackagers and relabelers. The FDA regulates Nitrumon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitrumon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Nitrumon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Nitrumon Suppliers

A Nitrumon supplier is an individual or a company that provides Nitrumon active pharmaceutical ingredient (API) or Nitrumon finished formulations upon request. The Nitrumon suppliers may include Nitrumon API manufacturers, exporters, distributors and traders.

click here to find a list of Nitrumon suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Nitrumon NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nitrumon as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Nitrumon API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Nitrumon as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Nitrumon and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nitrumon NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Nitrumon suppliers with NDC on PharmaCompass.

Nitrumon Manufacturers | Traders | Suppliers

Nitrumon Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.